Back to results
US 2009/0025098 A1Published application
Hepatitis C receptor protein CD81
AssigneeNovartis Vaccines and Diagnostics, Inc.
InventorsSergio Abrignani, Guido Grandi
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of CD81 protein and polynucleic acid in the therapy and diagnosis of hepatitis C and pharmaceutical compositions, animal models and diagnostic kits for such purposes.
Claims11
A transgenic, non-human mammal comprising a nucleotide sequence encoding a CD81 protein.
A method of producing a transgenic non-human mammal comprising introducing a nucleotide sequence encoding a CD81 protein into the embryo of said non-human mammal.
Dependencies are inferred from the claim text.